Skip to main content
. 2021 Jan 8;10:585551. doi: 10.3389/fonc.2020.585551

Figure 8.

Figure 8

MYBL2 High lung adenocarcinoma patient identification. (A) A 15 gene panel reliably identified MYBL2 High lung adenocarcinoma across TCGA and ORIEN cohorts. (B) MYBL2 High (N = 82) tumors significantly overexpress RAD51 (T-test, two-sided), XRCC1 (T-test, two-sided), and FOXM1 (T-test, two-sided) proteins, compared to MYBL2 Low (N = 91). MYBL2 High tumors also exhibit significantly decreased expression of NKX2-1 protein (T-test, two-sided), a key marker of lung differentiation.